Skip to main content
SpringerLink
Log in

Community-Acquired Viral Infections

  • Chapter
  • First Online:
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

  • 1727 Accesses

Abstract

Viral infections encountered in the outpatient setting incur substantial morbidity and mortality. Commonly encountered viruses causing clinically significant infections in this setting include two herpes viruses: Herpes simplex virus (HSV) and Varicella zoster virus (VZV), and two viruses causing respiratory infections: Influ-enza and Respiratory syncytial virus (RSV). The purpose of this chapter is to review the clinical syndromes and treatment op-tions for these viruses and the implications of antiviral resistance to their treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Fiore AE, Shay DK, Haber P et al. (2007). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56:1

    PubMed  Google Scholar 

  2. Zimmerman RK, Ruben FL, Ahwesh ER (1997). Influenza, influenza vaccine, and amantadine/rimantadine. J Fam Pract 45(2):107–122

    PubMed  CAS  Google Scholar 

  3. Cox NJ, Fukuda K (1998). Influenza. Infect Dis Clin North Am 12(1):27–38

    Article  PubMed  CAS  Google Scholar 

  4. Simonsen L, Clarke MJ, Schonberger LB et al. (1998). Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. J Infect Dis 78(1):53–60

    Google Scholar 

  5. Schwarzmann SW, Adler JL, Sullivan RJ, Jr. et al. (1971). Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med 127:1037

    Article  PubMed  CAS  Google Scholar 

  6. Dell KM, Schulman SL (1997). Rhabdomyolysis and acute renal failure in a child with influenza A infection. Pediatr Nephrol 11:363

    Article  PubMed  CAS  Google Scholar 

  7. Cunningham E, Kohli R, Venuto RC (1979). Influenza-associated myoglobinuric renal failure. JAMA 242:2428

    Article  PubMed  CAS  Google Scholar 

  8. Treanor JJ (2005). Influenza Virus. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases, 6th ed. Philadelphia, PA: Churchill Livingstone, 2060

    Google Scholar 

  9. Rodriguez WJ, Schwartz RH, Thorne MM (2002). Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J 21:193

    Article  PubMed  Google Scholar 

  10. Hayden FG, Fritz R, Lobo MC et al. (1998). Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101:643

    Article  PubMed  CAS  Google Scholar 

  11. Mossad SB (1999). Underused options for preventing and treating influenza. Cleve Clin J Med 66(1):19–23

    PubMed  CAS  Google Scholar 

  12. Fiore AE, Shay DK, Haber P et al. (2007). Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56:1

    PubMed  Google Scholar 

  13. Jacobs BC, Rothbarth PH, van der Meche FG et al. (1998). The spectrum of antecedent infections in Guillain-Barre syndrome:a case-control study. Neurology 51(4): 1110–1115

    PubMed  CAS  Google Scholar 

  14. Lasky T, Terracciano GJ, Magder L et al. (1998). The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Eng J Med 339(25):1797–1802

    Article  CAS  Google Scholar 

  15. Belshe RB, Mendelman PM, Treanor J et al. (1998). The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Eng J Med 338(20):1405–1412

    Article  CAS  Google Scholar 

  16. Treanor JJ, Mattison HR, Dumyati G et al. (1992). Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 117(8):625–633

    PubMed  CAS  Google Scholar 

  17. Cooper NJ, Sutton AJ, Abrams KR et al. (2003). Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials. BMJ 326:1235

    Article  PubMed  CAS  Google Scholar 

  18. Welliver R, Monto AS, Carewicz O et al. (2001). Effectiveness of oseltamivir in preventing influenza in household contacts: A randomized controlled trial. JAMA 285:748

    Article  PubMed  CAS  Google Scholar 

  19. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group (1998). Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352(9144):1877–1881

    Article  Google Scholar 

  20. Waghorn SL, Goa KL (1998). Zanamivir. Drugs 55(5):721–725; Discussion 725–727

    Article  PubMed  CAS  Google Scholar 

  21. Hayden FG, Osterhaus AD, Treanor JJ et al. (1997). Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Eng J Med 337(13):874–880

    Article  CAS  Google Scholar 

  22. Treanor JJ, Hayden FG, Vrooman PS et al. (2000). Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. JAMA 283:1016

    Article  PubMed  CAS  Google Scholar 

  23. Nicholson KG, Aoki FY, Osterhaus ADME et al. (2000). Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Lancet 355:1845

    Article  PubMed  CAS  Google Scholar 

  24. Hayden FG, Pavia AT (2006). Antiviral management of seasonal and pandemic influenza. J Infect Dis 194(Suppl 2):S119

    Article  PubMed  Google Scholar 

  25. http://www.cdc.gov/flu/weekly/index.htm

  26. Mishin VP, Hayden FG, Gubareva LV (2005). Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 49:4515

    Article  PubMed  CAS  Google Scholar 

  27. Whitley RJ, Kimberlin DW, Roizman B (1998). Herpes simplex viruses. Clin Infect Dis 26(3):541–553; quiz 554–555

    Article  PubMed  CAS  Google Scholar 

  28. Riley LE (1998). Herpes simplex virus. Semin Perinatol 22(4):284–292

    Article  PubMed  CAS  Google Scholar 

  29. Jacobs RF (1998). Neonatal herpes simplex virus infections. Semin Perinatol 22(1):64–71

    Article  PubMed  CAS  Google Scholar 

  30. Herpetic Eye Disease Study Group (1998). Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Eng J Med 339(5):300–306

    Article  Google Scholar 

  31. Jabs DA (1998). Acyclovir for recurrent herpes simplex virus ocular disease. N Eng J Med 339(5):340–341

    Article  CAS  Google Scholar 

  32. Levitz RE (1998). Herpes simplex encephalitis: A review. Heart Lung 27(3):209–212

    Article  PubMed  CAS  Google Scholar 

  33. Brown ZA, Selke S, Zeh J et al. (1997). The acquisition of herpes simplex virus during pregnancy. N Eng J Med 337(8):509–515

    Article  CAS  Google Scholar 

  34. Sacks SL (1999). Improving the management of genital herpes. Hosp Pract (Off Ed) 34(2):41–49; quiz 139

    Article  CAS  Google Scholar 

  35. Pottage J, Kessler H (1999). Herpes Simplex Virus Infections. In: Dolin R, Masur H, Saag M (eds) AIDS Therapy. Philadelphia, PA: Churchill Livingstone, 491–499

    Google Scholar 

  36. Baker DA (1998). Antiviral therapy for genital herpes in nonpregnant and pregnant women. Int J Fertil Womens Med 43(5):243–248

    PubMed  CAS  Google Scholar 

  37. Smith JR, Cowan FM, Munday P (1998). The management of herpes simplex virus infection in pregnancy. Br J Obstet Gynaecol 105(3):255–260

    Article  PubMed  CAS  Google Scholar 

  38. Scott LL, Alexander J (1998). Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Am J Perinatol 15(1):57–62

    Article  PubMed  CAS  Google Scholar 

  39. Scott LL, Sanchez PJ, Jackson GL et al. (1996). Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 87(1):69–73

    Article  PubMed  CAS  Google Scholar 

  40. Brocklehurst P, Kinghorn G, Carney O et al. (1998). A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 105(3):275–280

    Article  PubMed  CAS  Google Scholar 

  41. Whitley RJ, Kimberlin DW (1997). Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol 24(1):267–283

    PubMed  CAS  Google Scholar 

  42. Gaudreau A, Hill E, Balfour HH, Jr. et al. (1998). Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 178(2):297–303

    PubMed  CAS  Google Scholar 

  43. Cassady KA, Whitley RJ (1997). New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother 39(2):119–128

    Article  PubMed  CAS  Google Scholar 

  44. Wald A (1999). New therapies and prevention strategies for genital herpes. Clin Infect Dis 28(Suppl 1):S4–S13

    Article  PubMed  Google Scholar 

  45. Josephson A, Gombert ME (1998). Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 158(1):238–241

    Article  Google Scholar 

  46. Belay ED, Bresee JS, Holman RC et al. (1999). Reyes syndrome in the United States from 1981 through 1997. N Eng J Med 340(18):1377–1382

    Article  CAS  Google Scholar 

  47. Enders G, Miller E, Cradock-Watson J et al. (1994). Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases. Lancet 343(8912):1548–1551

    Article  PubMed  CAS  Google Scholar 

  48. Pastuszak AL, Levy M, Schick B et al. (1994). Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Eng J Med 330(13):901–905

    Article  CAS  Google Scholar 

  49. Opstelten W, Mauritz JW, de Wit NJ et al. (2002). Herpes zoster and postherpestic neuralgia: Incidence and risk indicators using a general practice research database. Fam Pract 19(5):471–475

    Article  PubMed  Google Scholar 

  50. Gregoire SM, van Pesch V, Goffette S et al. (2006). Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster infection of the nervous system. J Neurol Neurosurg Psychiatry 77(8):938–942

    Article  PubMed  CAS  Google Scholar 

  51. Grote V, von Kries R, Rosenfeld E et al. (2007). Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 196(10):1455–1458

    Article  PubMed  Google Scholar 

  52. American Academy of Pediatrics Committee on Infectious Diseases (1993). The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 91(3):674–676

    Google Scholar 

  53. Balfour HH, Jr., Rotbart HA, Feldman S et al. (1992). Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr 120(4 Pt 1):627–633

    PubMed  Google Scholar 

  54. Wallace MR, Bowler WA, Murray NB et al. (1992). Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med 117(5):358–363

    PubMed  CAS  Google Scholar 

  55. Asano Y, Yoshikawa T, Suga S et al. (1993). Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92(2):219–222

    PubMed  CAS  Google Scholar 

  56. Wood MJ, Kay R, Dworkin RH et al. (1996). Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials. Clin Infect Dis 22(2):341–347

    Article  PubMed  CAS  Google Scholar 

  57. Whitley RJ, Weiss H, Gnann JW, Jr. et al. (1996). Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 125(5):376–383

    PubMed  CAS  Google Scholar 

  58. Beutner KR, Friedman DJ, Forszpaniak C et al. (1995). Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39(7):1546–1553

    PubMed  CAS  Google Scholar 

  59. Tyring S, Barbarash RA, Nahlik JE et al. (1995). Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 123(2):89–96

    PubMed  CAS  Google Scholar 

  60. Centers for Disease Control and Prevention (2007). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 56(RR-4):1–40

    Google Scholar 

  61. Centers for Disease Control and Prevention (2006). A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR 55:209

    Google Scholar 

  62. Chaves SS, Garquillo P, Zhang JX et al. (2007). Loss of vaccine-induced immunity to varicella over time. N Eng J Med 356:1121

    Article  CAS  Google Scholar 

  63. Darville T, Yamauchi T (1998). Respiratory syncytial virus. Pediatr Rev 19(2):55–61

    Article  PubMed  CAS  Google Scholar 

  64. McCarthy CA, Hall CB (1998). Recent approaches to the management and prevention of respiratory syncytial virus infection. Curr Clin Top Infect Dis 18:1–18

    PubMed  CAS  Google Scholar 

  65. Sandritter TL, Kraus DM (1997). Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part I. J Pediatr Health Care 11(6):284–291; quiz 292–293

    Article  PubMed  CAS  Google Scholar 

  66. Mlinaric-Galinovic G, Falsey AR, Walsh EE (1996). Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis 15(10):777–781

    Article  PubMed  CAS  Google Scholar 

  67. Falsey AR (1998). Respiratory syncytial virus infection in older persons. Vaccine 16(18):1775–1778

    Article  PubMed  CAS  Google Scholar 

  68. Han LL, Alexander JP, Anderson LJ (1999). Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden. J Infect Dis 179(1):25–30

    Article  PubMed  CAS  Google Scholar 

  69. Ahluwalia G, Embree J, McNicol P et al. (1987). Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for RSV diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol 25:763

    PubMed  CAS  Google Scholar 

  70. Englund JA, Piedra PA, Jewell A et al. (1996). Rapid diagnosis of RSV infections in immunocompromised adults. J Clin Microbiol 34:1649

    PubMed  CAS  Google Scholar 

  71. Casiano-Colon AE, Hulbert BB, Mayer TK et al. (2003). Lack of sensitivity of rapid antigen tests for the diagnosis RSV infection in adults. J Clin Microbiol 28:169

    CAS  Google Scholar 

  72. Meert KL, Sarnaik AP, Gelmini MJ et al. (1994). Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind, randomized trial. Crit Care Med 22(4):566–572

    Article  PubMed  CAS  Google Scholar 

  73. Wheeler JG, Wofford J, Turner RB (1993). Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 12(3):209–213

    Article  PubMed  CAS  Google Scholar 

  74. Moler FW, Steinhart CM, Ohmit SE et al. (1996). Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. J Pediatr 128(3):422–428

    Article  PubMed  CAS  Google Scholar 

  75. American Academy of Pediatrics Committee on Infectious Diseases (1996). Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97(1):137–140

    Google Scholar 

  76. The IMpact-RSV Study Group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3 Pt 1):531–537

    Article  Google Scholar 

  77. Meissner HC, Long SS (2003). Revised indications for the use of Palivizumab and RSV immune globulin intravenous for the prevention of RSV infections. Pediatrics 112:1447

    Article  PubMed  Google Scholar 

  78. Feltes TF, Cabalka AK, Meissner HC et al. (2003). Palivizumab prophylaxis reduces hospitalization due to RSV in young children with hemodynamically significant congenital heart disease. J Pediatr 143:532

    Article  PubMed  CAS  Google Scholar 

  79. Sorrentino M, Powers T (2000). Effectiveness of Palivizumab: Evaluation of outcomes from the 1998 to 1999 RSV season. The Palivizumab Outcomes Study Group. Pediatr Infect Dis J 19:1068

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Internal Medicine, Medical University of South Carolina, Charleston, SC, USA

    Chris Parsons

Authors
  1. Chris Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris Parsons .

Editor information

Editors and Affiliations

  1. Dept. Family Medicine, Medical University of South Carolina, Calhoun St. 295, Charleston, 29425, U.S.A.

    Arch G. Mainous III

  2. School of Medicine, University of California, Davis, Davis, 95616, U.S.A.

    Claire Pomeroy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Parsons, C. (2010). Community-Acquired Viral Infections. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-239-1_5

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-238-4

  • Online ISBN: 978-1-60327-239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation